Sulzer Medica's new era marred by hip and knee saga
This article was originally published in Clinica
Executive Summary
Sulzer Medical has conceded that its new start as an independent company - following the spin-off last week from parent Sulzer - is "affected by the recall of the Inter-Op hip shells and the investigation on the tibial baseplates". The Swiss company, which will have a new name within a year, has seen its share price crumple amid worries over the implications of the product problems.